Australian cannabis company to enter US through $21 million CBD acquisition
Creso Pharma said it is buying Colorado-based CBD maker Sierra Sage Herbs in an all-stock deal worth $21…
News February 4
Latest In: CBD
Should marijuana extractors consider the mushroom market?
Growing decriminalization and interest in psilocybin have kept the potential future shroom boom on the marijuana industry's radar.
News February 4
NFTs: A scam – or a smart play for marijuana companies?
The NFT boom is coming for THC and CBD. Marijuana companies are rolling out nonfungible tokens (NFTs) to…
News February 2
Delta-8 Debate: The 2018 Farm Bill gave rise to an unlikely intoxicant
The 2018 U.S. Farm Bill unleashed large supplies of CBD distillate, which can be turned into a rare,…
News February 1
Is delta-8 THC a threat to the marijuana industry?
Delta-8 THC has been most popular in states where traditional delta-9 cannabis is prohibited or highly restricted, a…
News February 1
Rules governing delta-8 THC vary widely by state
The toughest job in cannabis right now might be keeping track of fast-moving laws surrounding a THC isomer…
News February 1
Is hemp-derived delta-8 THC causing consumer confusion?
Delta-8 THC dominated sales in hemp shops around the country in recent years. But is this trend affecting…
News February 1
Scientists believe bioreactors could augment cannabis agriculture
BioHarvest Sciences, a company that biosynthetically created grape and pomegranate extracts to sell to food ingredient companies and…
News February 1
The Controlled Substances Act leaves pathway for intoxicating hemp-derived cannabinoids
Delta-8 THC exploded onto the scene in 2019, followed by delta-10 THC, THC-O acetate and HHC in 2020…
News February 1
Widespread crackdown on delta-8 THC could pose a threat to other cannabinoids
Delta-8’s meteoric rise in popularity is forcing a conversation about how to regulate minor cannabinoids. Until recently, delta-8…
News February 1
Latest Sponsored
